Incannex Healthcare IXHL
NASDAQ IXHL
$3.35 -0.09 (-2.62%)
At close: Aug 20, 2026 · 10:43 AM UTC

Incannex Healthcare (IXHL) Shares Outstanding (2020 - 2026)

Incannex Healthcare (IXHL) posted Shares Outstanding (Entity) of $13.7 million for Q1 2026, up 14.27% sequentially from $12.0 million in Q4 2025, and up 1990.88% YoY from $654418.0 in Q1 2025.

Incannex Healthcare (IXHL) Shares Outstanding (2020 - 2026) Analysis & Trends

Incannex Healthcare has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $13.7 million in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 1990.88% year-over-year to $13.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $13.7 million (up 1990.88% YoY) and the FY2025 annual result came in at $1.1 million, up 95.29% from the prior year.
  • Shares Outstanding (Entity) climbed to $13.7 million in Q1 2026 per IXHL's latest filing, from $12.0 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $13.7 million in Q1 2026 and troughed at $11667.0 in Q2 2022.
  • A 5-year average of $2.9 million and a median of $588094.0 in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2022 and 2023: Shares Outstanding (Entity) sank 95.36% in 2022, then soared 4435.05% in 2023.
  • Over 5 years, Shares Outstanding (Entity) stood at $529103.0 in 2022, then advanced by 0.0% to $529104.0 in 2023, then increased by 12.05% to $592841.0 in 2024, then surged by 1919.76% to $12.0 million in 2025, then gained by 14.27% to $13.7 million in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $13.7 million, $12.0 million, and $11.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.58 Bn 42.62 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.27 Bn 39.62 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.78 Bn 22.99 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.42 Bn 19.76 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.79 Bn 17.91 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.64 Bn 15.25 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.12 Bn 11.59 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.09 Bn 9.92 Bn - 832.44 Mn
10 Incannex Healthcare 41.74 Mn 41.74 Mn - 12.35 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.35 Mn
Dec 31, 2025 11.65 Mn
Sep 30, 2025 10.34 Mn
Jun 30, 2025 1.15 Mn
Mar 31, 2025 654,418.00
Dec 31, 2024 587,481.00
Sep 30, 2024 588,094.00
Jun 30, 2024 538,811.00
Mar 31, 2024 529,104.00
Dec 31, 2023 529,104.00
Sep 30, 2023 529,104.00
Jun 30, 2023 512,823.00
Mar 31, 2023 529,104.00
Dec 31, 2022 513,279.00
Jun 30, 2022 11,667.00
Jun 30, 2021 251,372.00
Jun 30, 2020 16,667.00